Choose from over one hundred high-quality DNA FISH probes for the detection of genetic aberrations found in cancer and inherited genetic diseases.
Discover moreFeaturing the new constitutional NGS platform for cytogenetic research, alongside a broad range of arrays for rare disease and cancer research.
Discover moreChoose from preloaded NGS panels for haematological and solid tumour cancer research or we can help you create your own.
Discover moreWe believe that collaboration is key to improving patient lives. By sharing our knowledge and expertise, we ensure that we move forward with our customers, bound by a collective commitment to unlocking the future of genetic clinical care. See our story.
New integrated website, expanded resources and substantial worldwide support reaffirm partnership and commitment to customers.
ReadIn the workshop users will explain how OGT’s SureSeq™ NGS panels can increase throughput and save time and cost in the detection of a wide variety of aberrations.
ReadLaunch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders.
Read